Why is tacrolimus used in topical calcineurin inhibitors?

Eczema and some other inflammatory skin conditions involve immune signals that drive redness, itching, and a weakened barrier. Tacrolimus dampens activation of certain immune cells in the skin, which can reduce that inflammation. It is not a moisturiser, antibiotic, or instant numbing medicine, so barrier care remains part of treatment.

Because it does not work by thinning the skin, a clinician may consider it for areas such as the face, eyelids, folds, or other delicate sites. Burning, warmth, or itching can occur when treatment begins and often needs discussion if it is strong or persistent. Use is condition-specific and should follow the prescribed instructions.

Apply a thin layer to the affected skin exactly as directed, avoiding eyes, inside the mouth, and infected areas unless your clinician gives different instructions. Wash hands afterward and use moisturiser as advised. Tell the clinician about frequent infections, a weakened immune system, swollen glands, or medicines that affect immunity. Avoid unnecessary sun or tanning exposure and follow the product’s storage guidance.

Contact the prescriber for worsening redness, pus, crusting, painful blisters, or an eruption that does not settle. Seek urgent help for facial swelling, trouble breathing, or widespread blistering. Arrange review if the treated rash changes character, spreads despite use, or is accompanied by fever.

Ask why tacrolimus fits your diagnosis, where it should be applied, how to combine it with moisturiser, and what to do about early burning. Ask when you should return if the rash fails to improve or keeps recurring.